The Pathology of Biliary Tract Carcinoma (BTC)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 174
Special Issue Editor
Special Issue Information
Dear Colleagues,
There are several controversial issues within the pathology of biliary tract carcinoma. While two subtypes of intrahepatic cholangiocarcinoma (small duct and large duct type) were proposed in the WHO’s 2019 tumor classification, more studies and information are necessary to expand our understanding of their pathologic classification and characterization and the development of carcinoma. Several preinvasive lesions, such as IPNB and IOPN and ITPN and high-grade BilIN in the large bile ducts and pyloric gland adenoma, high-grade BilIN and ICPN in the gallbladder, were proposed in the WHO’s 2019 tumor classification; however, more pathological and genetic/molecular studies are needed to help us to understand these lesions. More studies are mandatory for the clarification of the precursors to small duct intrahepatic cholangiocarcinoma. The peribiliary glands and the interface between hepatocytes and bile ductules are two anatomical regions that contain hepatic/biliary/enteric stem cells, and more pathologic studies and reviews are mandatory to reveal the neoplasms that arise in these stem cell niches. We welcome both original studies and reviews on these controversial pathological fields in this Special Issue.
Dr. Yasuni Nakanuma
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bile duct
- gallbladder
- bile ductules
- precursors
- preinvasive neoplasm
- stem/progenitor cells
- cholangiocar-cinoma
- gallbladder carcinoma
- pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
